Extrait

This study is being conducted to evaluate the effectiveness and safety of LAMICTAL added to the current therapy of pediatric patients age 1-24 months old with partial seizures. The medication used in this study has been approved by FDA for the adjunctive treatment of partial seizures in patients 2 years and older.

Critère d'inclusion

• Epilepsy

Pays

• Australia
• Estonia
• France
• Hungary
• Italy
• Latvia
• Lebanon
• Lithuania
• Netherlands
• Portugal
• Slovakia
• Spain
• Turkey
• United States

Liens

• nct
• ictrp